Prior to joining Industrifonden, Patrik Sobocki held the position as business franchise leader with IMS Health responsible for data and technology business in Europe, Asia and Africa including responsibility for M&A in HealthTech. His previous experiences include having built two HealthTech start-ups which were both exited to US buyers (United Health Group and IMS Health), the last as CEO and part of integrating the technology into the global IMS Health tech stack and offering. Prior to that he held international R&D and commercial leadership roles with BigPharma companies in Glaxo Smith Kline and AstraZeneca.
Patrik Sobocki holds a Master of Science in Finance from the Stockholm School of Economics, a Master in international management from the Community of European Management Schools (CEMS) and a PhD in Medicine from Karolinska Institutet. He currently holds an Associate Professorship in health economics and epidemiology with Karolinska Institutet and has published research in over 40 international peer-reviewed journals.